3D In vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells.
about
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyondTowards a quantitative theory of epidermal calcium profile formation in unwounded skin.Use of induced pluripotent stem cells in dermatological research.Generation of KCL037 clinical grade human embryonic stem cell line.Generation of KCL039 clinical grade human embryonic stem cell line.Generation of KCL040 clinical grade human embryonic stem cell line.Generation of KCL021 research grade human embryonic stem cell line carrying a ΔF508 mutation in the CFTR geneGeneration of KCL034 clinical grade human embryonic stem cell line.Generation of KCL029 research grade human embryonic stem cell line carrying a mutation in WAS gene.Generation of KCL031 clinical grade human embryonic stem cell line.Generation of KCL024 research grade human embryonic stem cell line carrying a mutation in NF1 geneGeneration of KCL026 research grade human embryonic stem cell line carrying a mutation in SMN1 gene.Generation of KCL025 research grade human embryonic stem cell line carrying a mutation in NF1 gene.Generation of KCL012 research grade human embryonic stem cell line carrying a mutation in the HTT geneGeneration of KCL017 research grade human embryonic stem cell line carrying a mutation in VHL gene.Generation of KCL028 research grade human embryonic stem cell line carrying a mutation in the HTT geneGeneration of KCL013 research grade human embryonic stem cell line carrying a mutation in the HTT gene.Generation of KCL033 clinical grade human embryonic stem cell lineGeneration of KCL036 research grade human embryonic stem cell line carrying a mutation in the HTT geneEndoplasmic Reticulum Calcium Regulates Epidermal Barrier Response and Desmosomal Structure.Therapies for inherited skin fragility disorders.Current status of pluripotent stem cells: moving the first therapies to the clinic.Potential applications of keratinocytes derived from human embryonic stem cells.Progress and Future Prospectives in Skin-on-Chip Development with Emphasis on the use of Different Cell Types and Technical ChallengesInduced Pluripotent Stem Cell Differentiation and Three-Dimensional Tissue Formation Attenuate Clonal Epigenetic Differences in Trichohyalin.Concise Review: Human Embryonic Stem Cells-What Have We Done? What Are We Doing? Where Are We Going?Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing.Differentiation of equine induced pluripotent stem cells into a keratinocyte lineage.Baicalein increases keratin 1 and 10 expression in HaCaT keratinocytes via TRPV4 receptor activation.Effects of maternal obesity on Wharton's Jelly mesenchymal stromal cells.Rapid spheroid clearing on a microfluidic chip.Skin-on-a-Chip: Transepithelial Electrical Resistance and Extracellular Acidification Measurements through an Automated Air-Liquid Interface.Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development.The patch assay reconstitutes mature hair follicles by culture-expanded human cells.
P2860
Q26861563-D53B34FD-449D-4BB0-98B2-C37B248FC1F6Q35549914-94F96135-01BB-4357-85F5-4640792107D1Q35924230-5A41AF5A-8E4A-44E9-927A-201B5AE72148Q36061858-8BAF649B-228F-4A1B-A9F0-F0C89EFBE4B8Q36061862-B8DECA64-8902-4D8B-B3C4-C3BB7C8C1F95Q36061867-80457601-A593-4216-9794-72909A6B6388Q36061870-608A8E0B-1523-4091-81B2-B66397615222Q36061875-2DE14258-4783-4299-B854-396BBE7CAED4Q36061878-5C53BF75-7CBC-4609-8686-5AFE8ED1091DQ36061881-A5B62006-7F1D-4B47-8FF1-80E5366061B0Q36061892-16D8658E-E1C9-4A56-B56D-509935F195CFQ36061896-986DF2C0-0B87-46B8-B823-391B2A9092DFQ36061900-9CF467D1-190B-493A-BD87-8745ADF3047CQ36061905-74B256E0-F4F6-4F42-88A7-647F6379DC89Q36061909-97775D10-DFD1-45ED-8BB2-B78E5C8654B8Q36061916-049704A3-E00F-4A59-80CF-6A2B005209EEQ36061921-541A1900-971D-4F67-8D29-561918386B8AQ36061925-21DBC86A-6B35-44ED-8838-69C0466BDB0BQ36061934-3B8C5C85-4EE3-4AA3-ACB0-0B87763BA3F6Q37350637-4B883727-1EC1-4826-BEED-08AB6AAB7336Q38444460-659019CB-14AA-4976-8727-57AEE6545E90Q38590664-B6C7B3CE-EAD8-4C75-AE47-7E5AD3F42EAEQ38668504-95A7631F-7306-4D02-94C7-996FDD5CCB59Q38679988-3863B27C-206A-40D5-A720-93DD4E4D706FQ38755657-7FB378A8-1B7B-4E10-AC79-A9400EBD8D35Q38847809-853F7BE2-3F7D-4FA1-B8D3-718776FAE536Q38965137-ADA35CD4-4FB1-4194-88B9-EA8D5FB32204Q42474349-EC6C5D51-DE32-4F50-83C5-D26799F6FE01Q46566713-88107057-E005-4547-905A-74D83E71E065Q47109708-4CB4EB45-52C8-4B84-A023-BE46DF98D69FQ47297067-089050E2-1822-40C5-A49E-F4BDD0026122Q50025188-4016F10C-8966-461F-8003-F677286E3437Q51418460-FED21060-73C5-4DE2-967E-B40E33D01831Q53102053-3D305B90-92CC-4F5B-97E7-8745D3DB9BD4
P2860
3D In vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
3D In vitro model of a functio ...... nduced pluripotent stem cells.
@ast
3D In vitro model of a functio ...... nduced pluripotent stem cells.
@en
type
label
3D In vitro model of a functio ...... nduced pluripotent stem cells.
@ast
3D In vitro model of a functio ...... nduced pluripotent stem cells.
@en
prefLabel
3D In vitro model of a functio ...... nduced pluripotent stem cells.
@ast
3D In vitro model of a functio ...... nduced pluripotent stem cells.
@en
P2093
P2860
P50
P1433
P1476
3D In vitro model of a functio ...... nduced pluripotent stem cells.
@en
P2093
Aleksandra Cvoro
Anastasia Petrova
Anna Celli
Carl Hobbs
Debra Crumrine
Laureen Jacquet
Liani Devito
Lillian C Adame
Matthew Arno
Melanie Hupe
P2860
P304
P356
10.1016/J.STEMCR.2014.03.009
P577
2014-04-24T00:00:00Z